Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,314 | 85 | 98.1% |
| Education | $25.79 | 2 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $222.00 | 16 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $161.21 | 10 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $147.22 | 9 | $0 (2019) |
| Astellas Pharma US Inc | $141.39 | 8 | $0 (2020) |
| Novo Nordisk Inc | $105.41 | 7 | $0 (2020) |
| PFIZER INC. | $87.73 | 7 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $72.08 | 6 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $71.30 | 4 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $68.48 | 4 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $51.31 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $15.34 | 1 | Lilly USA, LLC ($15.34) |
| 2021 | $115.01 | 7 | SANOFI-AVENTIS U.S. LLC ($51.62) |
| 2020 | $128.92 | 7 | GlaxoSmithKline, LLC. ($45.64) |
| 2019 | $338.87 | 23 | Astellas Pharma US Inc ($67.32) |
| 2018 | $360.01 | 23 | Janssen Pharmaceuticals, Inc ($83.94) |
| 2017 | $381.23 | 26 | GlaxoSmithKline, LLC. ($104.20) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/29/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Diabetes | ||||||
| 09/21/2021 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/01/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Respiratory | ||||||
| 08/17/2021 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/09/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: RESPIRATORY | ||||||
| 06/30/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXELIS | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: VACCINE | ||||||
| 06/16/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/19/2021 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/16/2020 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: VACCINE | ||||||
| 08/19/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: VACCINES | ||||||
| 07/21/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Diabetes | ||||||
| 03/11/2020 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: VACCINES | ||||||
| 02/24/2020 | Novo Nordisk Inc | Tresiba (Drug), Victoza | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Diabetes | ||||||
| 01/06/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: UROLOGY | ||||||
| 01/03/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.17 | General |
| Category: Cardiovascular | ||||||
| 11/04/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: VACCINES | ||||||
| 10/29/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/21/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Diabetes | ||||||
| 08/28/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: UROLOGY | ||||||
| 08/15/2019 | Ironshore Pharmaceuticals Inc. | Jornay PM 20mg capsules (Bottle of 100) (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Central nervous system (CNS) stimulant | ||||||
| 07/31/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.36 | General |
| Category: Cardiovascular | ||||||
| 06/11/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Hypertriglyceridemia | ||||||
| 06/05/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.60 | General |
| Category: Cardiovascular | ||||||
| 05/20/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: UROLOGY | ||||||
| 05/17/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 360 | 494 | $70,170 | $18,413 |
| 2022 | 7 | 425 | 533 | $70,620 | $19,707 |
| 2021 | 7 | 509 | 654 | $83,715 | $46,231 |
| 2020 | 10 | 612 | 748 | $88,905 | $42,077 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 199 | $35,820 | $8,932 | 24.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 88 | 88 | $16,368 | $3,889 | 23.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 82 | $10,004 | $3,271 | 32.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 23 | 24 | $2,928 | $1,300 | 44.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 92 | 101 | $5,050 | $1,022 | 20.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 161 | $28,980 | $7,433 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 82 | 116 | $14,152 | $4,774 | 33.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 99 | 99 | $18,414 | $4,480 | 24.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 24 | 27 | $3,294 | $1,721 | 52.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 103 | 106 | $5,300 | $930.68 | 17.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $480.00 | $368.56 | 76.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 12 | 12 | $0.12 | $0.12 | 100.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 98 | 172 | $30,960 | $16,932 | 54.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 122 | 122 | $22,692 | $16,829 | 74.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 115 | 179 | $21,838 | $10,502 | 48.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 118 | 125 | $6,250 | $1,297 | 20.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 25 | 25 | $1,000 | $443.15 | 44.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 13 | $975.00 | $227.44 | 23.3% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 18 | 18 | $0.18 | $0.18 | 100.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 122 | 122 | $22,692 | $14,744 | 65.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 106 | 143 | $25,740 | $11,515 | 44.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 113 | 193 | $23,546 | $9,477 | 40.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 26 | 31 | $3,422 | $1,782 | 52.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 125 | 131 | $6,550 | $1,503 | 22.9% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 20 | 20 | $2,520 | $1,007 | 40.0% |
About Dr. Bruce Fischer, MD
Dr. Bruce Fischer, MD is a Internal Medicine healthcare provider based in Bristol, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598766552.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Fischer, MD has received a total of $1,339 in payments from pharmaceutical and medical device companies, with $15.34 received in 2022. These payments were reported across 87 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,314).
As a Medicare-enrolled provider, Fischer has provided services to 1,906 Medicare beneficiaries, totaling 2,429 services with total Medicare billing of $126,428. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bristol, RI
- Active Since 08/02/2005
- Last Updated 04/17/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1598766552
Products in Payments
- ELIQUIS (Drug) $177.70
- XARELTO (Drug) $135.85
- MYRBETRIQ (Drug) $87.29
- TRELEGY ELLIPTA (Drug) $59.97
- Myrbetriq (Drug) $54.10
- TOUJEO (Biological) $51.62
- ANORO (Drug) $46.95
- PNEUMOVAX 23 (Biological) $46.93
- Victoza (Drug) $44.56
- Tresiba (Drug) $44.19
- SHINGRIX (Biological) $42.15
- PREVNAR - 13 (Biological) $36.08
- FARXIGA (Drug) $33.34
- STIOLTO (Drug) $32.31
- ENTRESTO (Drug) $30.30
- NO PRODUCT DISCUSSED (Drug) $29.61
- BREO (Drug) $27.63
- LYRICA (Drug) $23.64
- Vascepa (Drug) $23.51
- SPIRIVA RESPIMAT (Drug) $23.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bristol
Dr. Bernard Grunstra, Md, MD
Internal Medicine — Payments: $36,895
Charles Villoch, Md, MD
Internal Medicine — Payments: $25,124
Dr. Joseph Foley, M.d, M.D
Internal Medicine — Payments: $21,160
Dr. Nathan Gargus, M.d, M.D
Internal Medicine — Payments: $17,677
Rick Whiles, Md, MD
Internal Medicine — Payments: $17,415
Dr. Donald Quinn, Md, MD
Internal Medicine — Payments: $17,216